Document is current
Any future updates will be listed below
-
Authors
Kristoffersen, Espen Saxhaug https://orcid.org/0000-0002-8999-5424
Faiz, Kashif Waqar
Hansen, Jakob Møller
Tronvik, Erling Andreas
Frich, Jan C.
Lundqvist, Christofer
Winsvold, Bendik Slagsvold
-
Funding
Funding for this research was provided by:
Akershus Universitetssykehus
Universitetet i Oslo
Oslo universitetssykehus
- License Information
-
More Information
Article History
Received: 1 October 2021
Accepted: 28 October 2021
First Online: 11 November 2021
Change Date: 19 December 2022
Change Type: Update
Change Details: Supplementary file has been added to the original article.
Declarations
:
: The Regional Committee for Medical Research Ethics reviewed the study and the Norwegian Social Science Data Services approved the study. Informed consent was obtained from all participants.
: Not applicable.
: CL has received speaking fees from Abbvie Pharma AS, Novartis AS, Lundbeck AS and Roche AS, Norway, unrelated to the present work CL has also received research sponsorship and payment for advisory board participation from Abbvie Pharma unrelated to the present work. EAT has received speaker honoraria from Allergan, Novartis, Teva, Roche and Lundbeck unrelated to the present work. EAT has received personal fees from global advisory boards from Amgen/Novartis and Eli-Lilly unrelated to the present work. EAT is a Palion Medical and Nordic Brain Tech shareholder; unrelated to the present work. JMH has received speaking fees from Lundbeck, TEVA and Novartis, unrelated to the present work. ESK, KWF, JCF and BSW report no conflicts of interest.
